Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
668.00    -11.00 (-1.62%)
Bid:
666.00
Ask:
670.00
Spread: 4.00 (0.601%)
Market Cap: £1.23b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Board Change

10 Oct 2005 10:00

Volex Group PLC10 October 2005 EMBARGOED UNTIL 10.00 A.M. MONDAY 10 OCTOBER 2005 VOLEX GROUP p.l.c. Board Change As part of the ongoing restructuring of the business, the Board of Volexannounces that it has decided to restructure its senior executive team with theconsolidation of the Group Finance and Corporate Affairs teams. As a result ofthis, Mark Ashcroft, Director of Corporate Affairs, Company Secretary and BoardDirector will resign from the Board of Volex and leave the Company on the 14thOctober. John Corcoran, Chief Executive of Volex said: "Mark has been with the Group for over 20 years and has contributed in asignificant way across legal and board matters as well as assumingresponsibility for resource management throughout the Group. I would like tothank him for his professionalism and dedication to Volex throughout all of hisyears with the Group and to wish him well for the future." Mark's responsibilities for General Counsel and Company Secretary matters willbe overseen by Derek Walter, Group Finance Director. For further information please contact: Volex Group p.l.c. Tel: 01925 830101John Corcoran, Group Chief ExecutiveDerek Walter, Group Finance Director Weber Shandwick Square Mile Tel: 020 7067 0700Chris Lynch/Nick Dibden This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.